Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

KDM2A integrates DNA and histone modification signals through a CXXC/PHD module and direct interaction with HP1.

Borgel J, Tyl M, Schiller K, Pusztai Z, Dooley CM, Deng W, Wooding C, White RJ, Warnecke T, Leonhardt H, Busch-Nentwich EM, Bartke T.

Nucleic Acids Res. 2017 Feb 17;45(3):1114-1129. doi: 10.1093/nar/gkw979.

2.

The von Willebrand factor predicted unpaired cysteines are essential for secretion.

Shapiro SE, Nowak AA, Wooding C, Birdsey G, Laffan MA, McKinnon TA.

J Thromb Haemost. 2014 Feb;12(2):246-54. doi: 10.1111/jth.12466.

3.

Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity.

Groen A, Romero MR, Kunne C, Hoosdally SJ, Dixon PH, Wooding C, Williamson C, Seppen J, Van den Oever K, Mok KS, Paulusma CC, Linton KJ, Oude Elferink RP.

Gastroenterology. 2011 Nov;141(5):1927-37.e1-4. doi: 10.1053/j.gastro.2011.07.042. Epub 2011 Aug 4.

PMID:
21820390
4.

The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function.

Hoosdally SJ, Andress EJ, Wooding C, Martin CA, Linton KJ.

J Biol Chem. 2009 Jun 12;284(24):16277-88. doi: 10.1074/jbc.M109.007849. Epub 2009 Apr 15.

5.

Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins.

Martin CA, Longman E, Wooding C, Hoosdally SJ, Ali S, Aitman TJ, Gutmann DA, Freemont PS, Byrne B, Linton KJ.

Protein Sci. 2007 Nov;16(11):2531-41. Epub 2007 Sep 28.

6.

Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein.

Zolnerciks JK, Wooding C, Linton KJ.

FASEB J. 2007 Dec;21(14):3937-48. Epub 2007 Jul 12.

PMID:
17627029
7.

Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes.

Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, Wooding C, Linton K, Alexander DR, Higgins CF.

Nat Cell Biol. 2005 Aug;7(8):808-16. Epub 2005 Jul 17.

PMID:
16025105
8.

Walk right in.

Wooding C.

Nurs Stand. 2000 Nov 8-14;15(8):61. No abstract available.

PMID:
11971476
9.

Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle.

Rosenberg MF, Velarde G, Ford RC, Martin C, Berridge G, Kerr ID, Callaghan R, Schmidlin A, Wooding C, Linton KJ, Higgins CF.

EMBO J. 2001 Oct 15;20(20):5615-25.

10.

Renal chloride channel, CLCN5, mutations in Dent's disease.

Cox JP, Yamamoto K, Christie PT, Wooding C, Feest T, Flinter FA, Goodyer PR, Leumann E, Neuhaus T, Reid C, Williams PF, Wrong O, Thakker RV.

J Bone Miner Res. 1999 Sep;14(9):1536-42.

11.

Localisation of X linked recessive idiopathic hypoparathyroidism to a 1.5 Mb region on Xq26-q27.

Trump D, Dixon PH, Mumm S, Wooding C, Davies KE, Schlessinger D, Whyte MP, Thakker RV.

J Med Genet. 1998 Nov;35(11):905-9.

12.

Mutational analysis of PHEX gene in X-linked hypophosphatemia.

Dixon PH, Christie PT, Wooding C, Trump D, Grieff M, Holm I, Gertner JM, Schmidtke J, Shah B, Shaw N, Smith C, Tau C, Schlessinger D, Whyte MP, Thakker RV.

J Clin Endocrinol Metab. 1998 Oct;83(10):3615-23.

PMID:
9768674
13.

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, Sampson J, Wass JA, Wheeler MH, Thakker RV.

Am J Hum Genet. 1998 Feb;62(2):232-44.

14.

Mapping of the gene encoding the B56 beta subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).

Forbes SA, Pannett AA, Bassett JH, Harding B, Wooding C, Thakker RV, Butler R, Ogilvie D, Anand R, Gaudray P, Weber G, Larsson C, Zhang CX, Calender A, Höppener JW, Lips CJ, Kas K.

Hum Genet. 1997 Sep;100(3-4):481-5.

PMID:
9272177
15.

Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36.

Williamson C, Pannett AA, Pang JT, Wooding C, McCarthy M, Sheppard MN, Monson J, Clayton RN, Thakker RV.

J Med Genet. 1997 Aug;34(8):617-9.

16.

Linkage studies of a Missouri kindred with autosomal dominant spondyloepimetaphyseal dysplasia (SEMD) indicate genetic heterogeneity.

Gertner JM, Whyte MP, Dixon PH, Pang JT, Trump D, Pearce SH, Wooding C, Thakker RV.

J Bone Miner Res. 1997 Aug;12(8):1204-9.

17.

Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis.

Pearce SH, Wooding C, Davies M, Tollefsen SE, Whyte MP, Thakker RV.

Clin Endocrinol (Oxf). 1996 Dec;45(6):675-80.

PMID:
9039332
18.

Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV.

QJM. 1996 Sep;89(9):653-69. Erratum in: QJM 1996 Dec;89(12):957-8.

PMID:
8917740
19.

Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.

Pearce SH, Trump D, Wooding C, Sheppard MN, Clayton RN, Thakker RV.

Clin Endocrinol (Oxf). 1996 Aug;45(2):195-200.

PMID:
8881452
20.

Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene.

Pang JT, Lloyd SE, Wooding C, Farren B, Pottinger B, Harding B, Leigh SE, Pook MA, Benham FJ, Gillett GT, Taggart RT, Thakker RV.

Hum Genet. 1996 Jun;97(6):732-41.

PMID:
8641689
21.

Construction of a YAC contig and an STS map spanning 3.6 megabase pairs in Xp22.1.

Trump D, Pilia G, Dixon PH, Wooding C, Thakrar R, Leigh SE, Nagaraja R, Whyte MP, Schlessinger D, Thakker RV.

Hum Genet. 1996 Jan;97(1):60-8.

PMID:
8557262
22.

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.

Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP, et al.

J Clin Invest. 1995 Dec;96(6):2683-92.

24.

Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22.

Pook MA, Wrong O, Wooding C, Norden AG, Feest TG, Thakker RV.

Hum Mol Genet. 1993 Dec;2(12):2129-34.

PMID:
8111383
25.

Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.

Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN.

J Clin Invest. 1993 Jun;91(6):2815-21.

26.

Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies.

Scheinman SJ, Pook MA, Wooding C, Pang JT, Frymoyer PA, Thakker RV.

J Clin Invest. 1993 Jun;91(6):2351-7.

27.

Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families.

Thakker RV, Wooding C, Pang JT, Farren B, Harding B, Anderson DC, Besser GM, Bouloux P, Brenton DP, Buchanan KD.

Ann Hum Genet. 1993 Jan;57(1):17-25.

PMID:
8101435
28.

Linkage analysis of two cloned DNA sequences, DXS197 and DXS207, in hypophosphatemic rickets families.

Thakker RV, Davies KE, Read AP, Tippett P, Wooding C, Flint T, Wood S, Kruse TA, Whyte MP, O'Riordan JL.

Genomics. 1990 Oct;8(2):189-93.

PMID:
1979046
29.

Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies.

Thakker RV, Davies KE, Whyte MP, Wooding C, O'Riordan JL.

J Clin Invest. 1990 Jul;86(1):40-5.

30.

Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.

Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, Besser GM, O'Riordan JL.

N Engl J Med. 1989 Jul 27;321(4):218-24.

PMID:
2568587
31.

The presence of Schistosoma mansoni in Montserrat Leeward Islands.

Tikasingh ES, Wooding CD, Long E, Lee CP, Edwards C.

J Trop Med Hyg. 1982 Feb;85(1):41-3.

PMID:
6978409
32.

Mothers' speech to young children: variation in context.

Dunn J, Wooding C, Hermann J.

Dev Med Child Neurol. 1977 Oct;19(5):629-38.

PMID:
913903
33.

Subarachnoid hemorrhage in children.

Mendoza RG, Wooding CH.

J Natl Med Assoc. 1966 May;58(3):163-4. No abstract available.

34.

Neurofibromatosis; report of cases in Negro subjects.

SCOTT RB, WOODING CH Jr.

AMA Am J Dis Child. 1952 Oct;84(4):446-56. No abstract available.

PMID:
12975827
35.

Terramycin in treatment of pneumonias of childhood; a report of 10 cases.

WOODING CH Jr, SCOTT RB.

J Pediatr. 1951 Apr;38(4):423-7. No abstract available.

PMID:
14825052
36.

Terramycin hydrochloride in the treatment of Salmonella choleraesuis bacteremia.

SCOTT RB, WOODING CH Jr.

Pediatrics. 1951 Mar;7(3):349-54. No abstract available.

PMID:
14827638
37.

Congenital aural fistula.

SCOTT RB, WOODING CH Jr.

J Pediatr. 1950 Jun;36(6):784-88. No abstract available.

PMID:
15422495
38.

Osteogenesis imperfecta congenita; report of a case in a Negro infant.

SCOTT RB, WOODING CH Jr.

J Pediatr. 1950 Mar;36(3):381-4, illust. No abstract available.

PMID:
15405419
39.

The laboratory as a necessity for a conclusive diagnosis.

WOODING CG.

J Natl Med Assoc. 1946 Mar;38:71-3. No abstract available.

PMID:
21019197
40.

The Laboratory as a Necessity for a Conclusive Diagnosis.

Wooding CG.

J Natl Med Assoc. 1946 Mar;38(2):71-3. No abstract available.

Supplemental Content

Loading ...
Support Center